G. Walmsley Graham, Director at Olema Pharmaceuticals, Inc. (OLMA), bought 1,401,522 shares at $6.75 ($9.5M) on 2024-12-13, disclosed to the SEC on 2024-12-18.
Open-market purchase of $9.5M OLMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.75 | 700,761 | $4.7M | 50.0% |
| 2 | $6.75 | 700,761 | $4.7M | 50.0% |
| Total | $6.75 avg | 1,401,522 | $9.5M | 100% |
| Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |
| OLMA | SELL | 2024-12-17 | $9.5M | — | Filing → |
| OLMA | SELL | 2024-06-06 | $17.4M | — | Filing → |